Aadi Bioscience Appoints Mohammad Hirmand, M.D. to Board of Directors
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...
Source: prnewswire.com
Supergen Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Supergen Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Supergen Inc Today - Breaking & Trending Today
Xenter, Inc. Appoints Industry Leaders Robert S. Langer, Elazer R. Edelman, David J. Bearss and Mark Stautberg to Board of Directors; Closes $12M Series A
Published: May 07, 2021 -Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health- SALT LAKE CITY--(BUSINESS WIRE)-- Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. The additional members are Robert S. Langer, an Institute Professor at MIT and the most cited...
Source: biospace.com
GT Biopharma Appoints Two New Independent Directors
GT Biopharma Appoints Two New Independent Directors News provided by Share this article Share this article BEVERLY HILLS, Calif., Jan. 19, 2021 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology platform today announced the appointment of Michael Breen and Rajesh Shrotriya MD to the Company's Board of Directors (the "Board"), effective immediately. Mr. Breen and Dr. Shrotriya bring strong operational skills, deep understanding of drug development and s...
Source: prnewswire.com